NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES Read more about NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES France10744355.8Filed on 2010-02-19
NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES Read more about NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES Germany10744355.8Filed on 2010-02-19
NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS Read more about NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS United Kingdom05824355.1Filed on 2005-11-03
NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS Read more about NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS France05824355.1Filed on 2005-11-03
NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS Read more about NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS Germany05824355.1Filed on 2005-11-03
High ASS1 Expressing Tumors Embody A Purine Rich Genomic Signature And Sensitivity To Purine Depletion Read more about High ASS1 Expressing Tumors Embody A Purine Rich Genomic Signature And Sensitivity To Purine Depletion Patent Cooperation TreatyPCT/IL2020/050708Filed on 2020-06-24
Chimeric Antigen Receptors Targeting CD-19 Read more about Chimeric Antigen Receptors Targeting CD-19 Australia2020267211Filed on 2020-11-11
17-BETA-HYDROXYWITHANOLIDES AND USE THEREOF IN TREATING CANCER Read more about 17-BETA-HYDROXYWITHANOLIDES AND USE THEREOF IN TREATING CANCER US Application 16/978,442Filed on 2020-09-04
ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS Read more about ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS US Patent 11,434,272Filed on 2020-11-23
CD206 MODULATORS THEIR USE AND METHODS FOR PREPARATION Read more about CD206 MODULATORS THEIR USE AND METHODS FOR PREPARATION Patent Cooperation TreatyPCT/US2020/065238Filed on 2020-12-16